Synaptogenix, Inc. (NASDAQ:SNPX) Short Interest Update

by · The Markets Daily

Synaptogenix, Inc. (NASDAQ:SNPX – Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 19,800 shares, a growth of 725.0% from the December 15th total of 2,400 shares. Based on an average daily volume of 26,400 shares, the short-interest ratio is currently 0.8 days. Approximately 1.5% of the shares of the stock are short sold.

Synaptogenix Price Performance

Shares of SNPX traded up $0.21 during mid-day trading on Monday, hitting $3.34. 31,339 shares of the company traded hands, compared to its average volume of 44,934. The business has a 50-day moving average of $2.99 and a 200 day moving average of $3.36. Synaptogenix has a one year low of $2.32 and a one year high of $7.22.

Synaptogenix (NASDAQ:SNPX – Get Free Report) last released its earnings results on Tuesday, November 12th. The company reported ($4.58) EPS for the quarter, missing the consensus estimate of ($1.95) by ($2.63).

About Synaptogenix

(Get Free Report)

Synaptogenix, Inc operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It also evaluates therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease.

Featured Articles